Phoenix Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-19,775
Closed -$2.1M 398
2024
Q2
$2.1M Buy
+19,775
New +$1.99M 0.03% 182
2023
Q4
Sell
-10,657
Closed -$1.1M 372
2023
Q3
$1.1M Buy
10,657
+5,019
+89% +$509K 0.02% 223
2023
Q2
$559K Buy
+5,638
New +$564K 0.01% 241

Other funds holding NVS

Phoenix Financial's NVS Position: Q3 2024 in Review

Phoenix Financial sold out of Novartis (NVS) in Q3 2024, closing a stake of 19,775 shares — an estimated $2.1M sold.

Phoenix Financial first reported a position in NVS in Q2 2023 and held it in 3 quarters. The position peaked at $2.1M in Q2 2024. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • Phoenix Financial reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • Phoenix Financial sold 19,775 Novartis shares in Q3 2024, an estimated $2.1M.
  • Phoenix Financial first reported a position in Novartis in Q2 2023 and held it in 3 quarters.
  • Phoenix Financial's Novartis position peaked at $2.1M in Q2 2024.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on Phoenix Financial's 13F filing for Q3 2024, filed 5 Nov 2024.